Fool.com
The World's Greatest Investing Community
Results 51 - 60 of 1085 : Previous 2 3 4 5 6 7 8 9 10 Next
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
Should You Dump These Dividend Stocks?
Yields are looking thinner.
Thursday's Biggest Stock Stars
Yesterday's market is today's moneymaking road map.
World's Scariest Stocks: Pfizer
It may be a known unknown, but it still gives me the willies.
Come On -- They Represent Your Mom!
A fight with AARP proves that we're seeing politics as usual.
Now Is the Time to Invest and Get Rich
Or is the market a sucker's bet?
Pharma Researchers Need a Cure
As the industry changes, Pharmaceutical Product Development and Parexel International struggle.
This Common Move Will Get You Nowhere
Don't give up on your retirement.
Saved by Emerging Markets. Sort Of.
GlaxoSmithKline's top line looks good, but the bottom is what counts.
Pfizer's and Merck's Loss Is These Companies' Gain
Too busy integrating to take advantage of additional acquisitions.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK